Most importantly, while our data indicates that both homeostatic activation of JNK and NF-κB pathways are restrained by the IL-17RC-A20 axis, it is the JNKs and not the NF-κB pathway that are responsible for controlling homeostatic tumor-dependent proliferation. This evidence concerns the gene IL17RC and neoplasm.